XGES.L vs. GXLV.L
XGES.L (Xtrackers MSCI Genomic Healthcare Innovation UCITS ETF 1C) and GXLV.L (SPDR S&P US Health Care Select Sector UCITS ETF) are both Health & Biotech Equities funds tracking the MSCI World/Health Care NR USD, from DWS and State Street respectively. Both are passively managed. Over the past 3 years, XGES.L returned 1.51%/yr vs 3.78%/yr for GXLV.L. At a 0.31 correlation, their price movements are largely independent. XGES.L charges 0.35%/yr vs 0.15%/yr for GXLV.L.
Performance
XGES.L vs. GXLV.L - Performance Comparison
Loading charts...
Returns By Period
In the year-to-date period, XGES.L achieves a -0.81% return, which is significantly higher than GXLV.L's -1.77% return.
XGES.L
- 1D
- 4.22%
- 1M
- 6.75%
- YTD
- -0.81%
- 6M
- -4.42%
- 1Y
- 26.00%
- 3Y*
- 1.51%
- 5Y*
- —
- 10Y*
- —
GXLV.L
- 1D
- 2.97%
- 1M
- 5.67%
- YTD
- -1.77%
- 6M
- -2.12%
- 1Y
- 16.12%
- 3Y*
- 3.78%
- 5Y*
- —
- 10Y*
- —
XGES.L vs. GXLV.L - Yearly Performance Comparison
| 2026 (YTD) | 2025 | 2024 | 2023 | 2022 | |
|---|---|---|---|---|---|
XGES.L Xtrackers MSCI Genomic Healthcare Innovation UCITS ETF 1C | -0.81% | 11.22% | -1.38% | -7.92% | -8.46% |
GXLV.L SPDR S&P US Health Care Select Sector UCITS ETF | -1.77% | 6.82% | 3.59% | -3.78% | 5.69% |
Correlation
The correlation between XGES.L and GXLV.L is 0.43, which is low. Their price movements are largely independent, making them effective diversification partners.
| Correlation | |
|---|---|
Correlation (1Y) Calculated over the trailing 1-year period | 0.43 |
Correlation (3Y) Calculated over the trailing 3-year period | 0.32 |
Correlation (All Time) Calculated using the full available price history since Jul 21, 2022 | 0.31 |
The correlation between XGES.L and GXLV.L shifts across timeframes, from 0.31 (all time) to 0.43 (1 year), reflecting how their relationship changes across market environments.
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Return for Risk
XGES.L vs. GXLV.L — Risk / Return Rank
XGES.L
GXLV.L
XGES.L vs. GXLV.L - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for Xtrackers MSCI Genomic Healthcare Innovation UCITS ETF 1C (XGES.L) and SPDR S&P US Health Care Select Sector UCITS ETF (GXLV.L). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
| XGES.L | GXLV.L | Difference | |
|---|---|---|---|
| Sharpe ratioReturn per unit of total volatility | +0.12 | ||
| Sortino ratioReturn per unit of downside risk | +0.11 | ||
| Omega ratioGain probability vs. loss probability | 1.25 | 1.24 | +0.01 |
| Calmar ratioReturn relative to maximum drawdown | 1.69 | 2.16 | -0.46 |
| Martin ratioReturn relative to average drawdown | 4.09 | 4.76 | -0.67 |
Data is calculated on a 1-year rolling basis and updated daily. The trend shows the change in the indicator over the past month. | |||
Loading charts...
Sharpe Ratios by Period
| XGES.L | GXLV.L | Difference | |
|---|---|---|---|
Sharpe Ratio (1Y)Calculated over the trailing 1-year period | 1.45 | 1.34 | +0.12 |
Sharpe Ratio (All Time)Calculated using the full available price history | -0.12 | 0.31 | -0.44 |
Drawdowns
XGES.L vs. GXLV.L - Drawdown Comparison
The maximum XGES.L drawdown since its inception was -35.79%, which is greater than GXLV.L's maximum drawdown of -19.59%. Use the drawdown chart below to compare losses from any high point for XGES.L and GXLV.L.
Loading charts...
Drawdown Indicators
| XGES.L | GXLV.L | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -35.79% | -19.59% | -16.20% |
Max Drawdown (1Y)Largest decline over 1 year | -15.29% | -11.51% | -3.78% |
Max Drawdown (3Y)Largest decline over 3 years | -25.52% | -19.59% | -5.93% |
Current DrawdownCurrent decline from peak | -12.59% | -5.07% | -7.52% |
Average DrawdownAverage peak-to-trough decline | -17.98% | -6.15% | -11.83% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 6.34% | 9.07% | -2.73% |
Volatility
XGES.L vs. GXLV.L - Volatility Comparison
Xtrackers MSCI Genomic Healthcare Innovation UCITS ETF 1C (XGES.L) has a higher volatility of 6.45% compared to SPDR S&P US Health Care Select Sector UCITS ETF (GXLV.L) at 5.53%. This indicates that XGES.L's price experiences larger fluctuations and is considered to be riskier than GXLV.L based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Loading charts...
Volatility by Period
| XGES.L | GXLV.L | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | 6.45% | 5.53% | +0.92% |
Volatility (6M)Calculated over the trailing 6-month period | 13.62% | 12.37% | +1.25% |
Volatility (1Y)Calculated over the trailing 1-year period | 17.84% | 18.62% | -0.78% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 18.27% | 20.60% | -2.33% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 18.27% | 20.60% | -2.33% |
XGES.L vs. GXLV.L - Expense Ratio Comparison
XGES.L has a 0.35% expense ratio, which is higher than GXLV.L's 0.15% expense ratio.
Dividends
XGES.L vs. GXLV.L - Dividend Comparison
Neither XGES.L nor GXLV.L has paid dividends to shareholders.
Frequently Asked Questions
XGES.L and GXLV.L have a correlation of 0.43, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.
On fees, GXLV.L is cheaper at 0.15% per year. The better choice depends on whether you care most about return, fees, risk, or income.
GXLV.L is cheaper with a 0.15% expense ratio, compared with 0.35% for XGES.L.
Both ETFs track MSCI World/Health Care NR USD. They also come from different issuers: DWS and State Street. Their fees differ too: 0.35% for XGES.L and 0.15% for GXLV.L.
Find the right allocation for XGES.L and GXLV.L
Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio Optimizer